Irvine, CA – July 1, 2024 – Nihon Kohden, a global leader in medical devices and solutions, has appointed Roy Sakai as its new President of Nihon Kohden America, LLC (NKA), effective April 1st. Sakai succeeds Eiichi (Eddie) Tanaka in this role.
Sakai brings 25 years of healthcare industry experience to Nihon Kohden. His priorities are addressing customer needs for efficiency, cybersecurity, and self-sufficiency.
“Healthcare is evolving rapidly, creating opportunities for innovation,” said Sakai. “Our team’s culture of trust and teamwork positions us to meet providers’ changing needs through agility and creativity."
On his predecessor’s contributions, Sakai noted, “Eddie has set a strong foundation. I’m honored to build on his work and lead NKA into its next chapter.”
NKA aims to leverage its workforce, customer focus, and subsidiary synergies to drive growth and enhance customer experiences nationwide.
Eiichi (Eddie) Tanaka, CEO of Nihon Kohden North America, stated, “Roy's customer- focused approach and our talented team will drive growth through collaboration and new opportunities.”
About Nihon Kohden
Founded in 1951, Nihon Kohden is a global leader in medical technology committed to advancing patient care through innovative solutions. For over 70 years, Nihon Kohden has provided precision medical devices for heart, lung, and brain care, including EEG systems, patient monitors, defibrillators, and ventilators. Known for its pioneering work, such as developing the world’s first AC-powered EEG and contributing to the invention of pulse oximetry, Nihon Kohden integrates medical devices with IT networks to offer comprehensive healthcare solutions. With products used in over 120 countries, Nihon Kohden is the world’s largest supplier of electroencephalography products.
MEDIA CONTACT:
Beth Abbott
Senior Manager - Marketing Brand & Omnichannel